We evaluated the activity of the 47VHH1H4B anti-CD47 nanobody using an apoptosis assay, specifically targeting the U937 monocytic lymphoma cell line known for its pronounced CD47 surface expression. The gene discussed is CD47; the disease is lymphoma.